| Cas No.: | 1242137-15-0 |
| Chemical Name: | Enzalutamide Carboxylic Acid |
| Synonyms: | Desmethyl-enzalutamide;Enzalutamide Carboxylic Acid;Enzalutamide carboxylic acid |
| SMILES: | CC1(C)C(=O)N(C2=CC(=C(C=C2)C#N)C(F)(F)F)C(=S)N1C3=CC(=C(C=C3)C(=O)O)F |
| Formula: | C20H13F4N3O3S |
| M.Wt: | 451.394 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Enzalutamide carboxylic acid (MDV3100 carboxylic acid) is an inactive metabolite of Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist[1]. |
| In Vitro: | Enzalutamide is converted into its major metabolites, N-desmethyl enzalutamide and carboxylic acid enzalutamide, by cytochrome P450 (CYP) 3A4/5 and CYP2C8, respectively. N-desmethyl enzalutamide has clinically relevant anti-androgen capacities similar to enzalutamide, whereas carboxylic acid enzalutamide is inactive[1]. |
| References: | [1]. van Nuland M, et al. Exposure-Response Assessment of Enzalutamide and Its Major Metabolites in a Real-World Cohort of Patients with Metastatic Castration-Resistant Prostate Cancer. Pharmacotherapy. 2019 Dec;39(12):1137-1145. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
